Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06010758 · ClinicalTrials.gov registry record · Phase 4
A Two-Week Study of an Anticavity Low pH Mouthwash
A Phase 4 study of Healthy, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- Completed
- Registry status
- Phase 4
- Development phase
- 163
- Enrollment target
- 1
- Study location
NCT06010758 is a Phase 4 study of Healthy that has completed, run by Johnson & Johnson Consumer Inc. (J&JCI). The registered enrollment target is 163 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06010758, a Phase 4 study of Healthy, has completed, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 163 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this clinical trial is to evaluate the oral tolerance of a new, experimental mouthwash compared to two mouth rinse formulations, which are already marketed, as well as compared to a tooth brushing only control group.
Conditions Studied
Interventions
- DRUG Listerine Experimental Mouthwash
- DRUG Colgate Cavity Protection Toothpaste
- DRUG Listerine Total Care Zero
- OTHER Listerine Cool Mint Zero
Study Locations (1)
Indiana
- Salus Research, Inc. - Fort Wayne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2023-07-17 |
| Est. Completion | 2023-08-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06010758
The ClinicalTrials.gov registry entry for NCT06010758 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (75% lower). The listed sponsor is Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 4 interventions - of which Listerine Experimental Mouthwash is the first listed.
NCT06010758 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT06010758 about?
NCT06010758 is a clinical study titled "A Two-Week Study of an Anticavity Low pH Mouthwash". The purpose of this clinical trial is to evaluate the oral tolerance of a new, experimental mouthwash compared to two mouth rinse formulations, which are already marketed, as well as compared to a tooth brushing only control group.
What is the current status of trial NCT06010758?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 163 participants. The study started on 2023-07-17. Estimated completion is 2023-08-03.
What conditions does trial NCT06010758 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT06010758?
The interventions under investigation include: Listerine Experimental Mouthwash (DRUG), Colgate Cavity Protection Toothpaste (DRUG), Listerine Total Care Zero (DRUG), Listerine Cool Mint Zero (OTHER).
Who is sponsoring clinical trial NCT06010758?
This trial is sponsored by Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06010758 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of Acute Melatonin Supplementation on Cardiovascular Responses to Sympathetic Activation
RECRUITING · Phase 4
-
Effects of GH and Lirglutide on AgRP
RECRUITING · Phase 4
-
Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI
RECRUITING · Phase 4
-
Endothelial Derived Hyperpolarization Factor and Vascular Control
RECRUITING · Phase 4
-
Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion
ACTIVE NOT RECRUITING · Phase 4
-
Pharmacokinetics of Transdermal Metronidazole
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.